-+ 0.00%
-+ 0.00%
-+ 0.00%

Cellebrite clarifies equity plan dilution at 9.2% after shareholder inquiries

PUBT·09/02/2026 21:21:36
Listen to the news
Cellebrite clarifies equity plan dilution at 9.2% after shareholder inquiries
  • Cellebrite issued a Form 6-K clarification on dilution figures in its 2026 annual meeting proxy statement.
  • As of Aug. 1, 2026, 251,341,060 shares were outstanding; 25,554,161 shares were reserved for equity plans.
  • Fully diluted shares totaled 276,895,221, implying potential dilution of about 9.2%.
  • The share reserve reflected a 3,500,000-share reduction in the 2021 incentive plan pool, effective July 29, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellebrite DI Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-096800), on September 02, 2026, and is solely responsible for the information contained therein.